1. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018) Authors: Chaparro, M; Verreth, A; Lobaton, T; Gravito‐Soares, E; Julsgaard, M; Savarino, E; Magro, F; Biron, Avni I; Lopez‐Serrano, P; Casanova, M J; Gompertz, M; Vitor, S; Arroyo, M; Pugliese, D; Zabana, Y; Vicente, R; Aguas, M; Shitrit, Bar‐Gil A; Gutierrez, A; Doherty, G A Journal: American journal of gastroenterology Issue: Volume 113:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P512 Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis. (25th January 2019) Authors: Pugliese, D; Mendolaro, M; D'Incà, R; Ribaldone, D G; Principi, M; Ricci, C; Stasi, E; Scribano, M L; Bodini, G; Saibeni, S; Privitera, A C; Simondi, D; Armuzzi, A; Daperno, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗